| abstract |
Diclonin or a pharmaceutically acceptable salt thereof in combination with an antimicrobial agent selected from mupirocin, 4-methyl-1- (2-phenylethyl) -8-phenoxy-2,3-dihydro-1H-pyrrolo [3,2-c ] -quinoline, 4- (3- benzylpyrrolidin-1-yl) -2-methyl-6-phenoxyquinoline, and N- [4- (3-benzylpyrrolidin-1-yl) -2-methylquinolin-6-yl] benzamide or pharachetically acceptable salts thereof for use in the elimination of clinically latent microorganisms associated with a microbial infection. |